Jeder fA1/4nfte Deutsche leidet unter Reizdarmbeschwerden. Vielleicht auch Sie? Dieses Buch verspricht Linderung bei Durchfall oder Verstopfungen, BlAhungen und Schmerzen. Der Internist und ErnAhrungsmediziner Dr. Matthias Robert beschreibt, was sich hinter dem Reizdarmsyndrom verbirgt, welche so gar nicht reizenden Symptome es mit sich bringt und welche Untersuchungen Ihr Arzt bei Ihnen durchfA1/4hrt, um die Diagnose stellen und andere Erkrankungen ausschlieA en zu kAnnen. Er erklArt, wie das komplexe Organ Darm funktioniert, wie eng Bauch und Hirn verbunden sind und warum deshalb Psyche und Stress eine so groA e Rolle beim Reizdarmsyndrom spielen. Vor allem aber setzt er sich mit den verschiedenen MAglichkeiten der Therapie auseinander und stellt eine ganze Reihe von MAglichkeiten vor, wie Sie Ihre Beschwerden lindern kAnnen: ErnAhrungsumstellung und Entspannung, Medikamente und alternative Heilmethoden. Damit endlich Ruhe in Ihrem Bauch einkehrt.

Thanks to new tools of research and the heightened scientific rigor with which they are applied, medical science has reached a far more heightened understanding of nutrition s complex relation with digestive disease.
Nutritional Management of Digestive Disorders bring together the contributions of leading experts in nutrition and digestion to provide readers with a concise yet thorough record of the advances made in this area of research. In addition to discussing traditional areas of nutrition, it presents essential findings on more recent and novel therapies.

Specific Therapeutic Approaches to Specific Digestive Concerns

Among the specific topics, it describes celiac disease and eosinophilic esophagitis and their management through diet. It considers the role of nutrition in treating acute pancreatitis and liver disease, the role of macro- and micronutrients in preventing colon cancer, and the role of nutrition and dietary supplements in inflammatory bowel disease. Among emerging topics, it considers

• Guidelines for the use of probiotics to ease irritable bowel syndrome and antibiotic-associated diarrhea
• Bariatric surgery for the treatment of obesity
• Short bowel syndrome and small intestinal transplantation
• Expanding metal stents used to overcome malignant obstructions of the upper gastrointestinal (GI) tract
• Nutrition s role in treating acute pancreatitis and liver disease

Chapters in the book are dedicated to modern approaches to nutritional assessment, parenteral nutrition, and home nutritional support. Putting those recent developments into perspective, the book begins with a chapter that recounts the history of nutritional therapy in gastrointestinal disorders. Offering a cutting edge look at the field, Nutritional Management of Digestive Disorders provides researchers with critical data needed to conduct further research, while also providing clinicians with a look at new approaches to effective treatment.

Hepatology is an expanding field -- it's hard to keep up. The liver has been sitting there the whole time, but the knowledge surrounding this perplexing organ is exploding; this makes it hard to prepare for board and recertification exams, where 1 in every 4 questions pertains to hepatology. Until now, there has been no single, slim, but high-yield volume that summarizes the hepatology you need to know for the boards. This book has it nailed. The authors have collected every pearl of wisdom, high-yield factlet, liver "board buzzword," hepatic micrograph, and classic liver imaging study they could muster, all while keeping the book a manageable size - because who has time for more than manageable when you're busy? The answer to your study questions (and study time ) can be found inside: Acing the Hepatology Questions on the GI Board Exam: The Ultimate Crunch-Time Resource. Traditional textbooks usually feature long and detailed discussions that are not directly related to Board and recertification exams. On the flip side, many Board review manuals provide lists and bullet points lacking sufficient background and context. Inside Acing the Hepatology Questions on the GI Board Exam, Drs. Brennan Spiegel and Hetal Karsan present time-tested and high-yield information in a rational, useful, and contextually appealing format. Why You Will Need to Read Acing the Hepatology Questions on the GI Board Exam: * Focuses exclusively on Hepatology review -- an area that comprises 25% of the Board exam * Carefully vetted board-style vignettes with color images * Comprehensive yet succinct answers using a high-yield format * Emphasis on key clinical pearls and "board buzzwords" * Answers to classic board "threshold values" questions that you need to know but always seem to forget: If an echinococcal liver cyst exceeds XX cm, then the risk of rupture is clinically significant and surgery is warranted * Rapid fire crunch-time exam with 135 classic

Are you looking for concise, practical answers to questions that are often left unanswered by traditional GERD references? Are you seeking brief, evidence-based advice for complicated cases or complications? "Curbside Consultation in GERD: 49 Clinical Questions" provides quick and direct answers to the thorny questions commonly posed during a "curbside consultation" between colleagues.
Dr. Philip Katz has designed this unique reference, which offers expert advice, preferences, and opinions on tough clinical questions commonly associated with GERD. The unique Q&A format provides quick access to current information related to GERD with the simplicity of a conversation between two colleagues. Numerous images, diagrams, and references are included to enhance the text and to illustrate the treatment of GERD patients.
"Curbside Consultation in GERD: 49 Clinical Questions" provides information basic enough for residents while also incorporating expert advice that even high-volume clinicians will appreciate. Gastroenterologists, fellows and residents in training, surgical attendings, and surgical residents will benefit from the user-friendly and casual format and the expert advice contained within.
Some of the questions that are answered:
- Can medical therapy alter the natural history of Barrett's esophagus?
- Can antireflux surgery alter the natural history of Barrett's esophagus?
- How does pregnancy affect GERD? Is GERD in pregnancy a risk for long-term reflux?
- What is the association of obesity and GERD?
- What are the so-called extraesophageal manifestations of GERD?
- Is there a gender difference in reflux disease? Does this affecttreatment?

Colorectal cancer is the third most commonly diagnosed cancer in the US and the third most recently linked to cancer deaths. The national annual incidence rate of colorectal cancer is approximately 148,000+, striking slightly more females than males. The lifetime risk of colorectal cancer is 5-6%, however patients with a familial risk (with two or more first or second degree relatives) make up 20% of the patients. Persons who carry genetic mutations linked to hereditary colorectal cancer are the most likely to develop the disease.

This book, the proceedings of the Falk Syposium No. 139 on "Gallstones: Pathogenesis and Treatment", held in Freiburg, Germany, on January 15-16, 2004, reflects the tremendous advances in the field of biliary diseases both at the genetic and cellular as well as the clinical levels. In industrialized countries, gallstones are a frequent clinical entity with a prevalence of 10-15%. In clinical practice one can differentiate between cholesterol stones, black pigment stones and brown pigment stones. 80-90% of gallbladder stones are cholesterol stones, 10--20% are black pigment stones. The prevalence of cholesterol stones increases with age and in Europe in the 70+ age group reaches about 20% in males and about 30% in females. Gallstones and gallstone diseases, therefore, are a frequent and important clinical problem. The book addresses the basic aspects of gallstone pathogenesis as well as the non-surgical and surgical treatment of gallstone diseases. Of particular interest are the epidemiology and genetics of gallstone formation, with definition of risk factors, in particular of genetic predispositions. Other major aspects are the hepatocellular and bilary transport mechanisms that predispose to the formation of gallstones. Apart from cholesterol and lipid transport and absorption, gallbladder function plays a central role in gallstone formation. Another clinically very relevant topic is the treatment of gallstone diseases by drugs, endoscopic and other non-surgical interventions, and surgery, as well as the long-term outcome of therapeutic interventions. The volume concludes with a state-of-the-art chapter on "Gallstone Research in the Post-Genomic Era". Gallstones: Pathogenesis and Treatment is an excellent update on the pathogenesis of gallstones as well as on the treatment of gallstone diseases, written by an international faculty of outstanding clinicans and scientists. The book will, therefore, be of great interest to hepatologists and gastroenterologists in academic institutions as well as in clinical practice.

Inflammatory Bowel Disease: From Bench to Bedside is a detailed and comprehensive story of the local and systemic pathophysiology of intestinal inflammation including management strategies. Research advances and current concepts of etiopathogenesis in the context of what is already known of the clinicopathologic features of these disorders is explored. This volume blends recent advances in the basic and clinical sciences as they relate to inflammatory bowel disease and emphasizes the effectiveness of a team approach of basic scientists and clinician investigators in this field.

This book is based on the proceedings of the Enteric Nervous System conference in Adelaide, Australia, under the auspices of the International Federation for Neurogastroenterology and Motility. The book focuses on methodological strategies and unresolved issues in the field and explores where the future is heading and what technological advances have been made to address current and future questions. The Enteric Nervous System II continues in the tradition of a popular earlier volume which covered the previous meeting. Many of the same authors are contributing to this new volume, presenting state-of-the-art updates on the many developments in the field since the earlier meeting. The coverage include a wide range of topics, from structure and function of the enteric nervous system through gut motility and visceral pain. The author team includes long-established authorities who significantly contributed to the advances in ENS research over the past two decades and the new generation that will continue to contribute to advancing our understanding of the field.

Nutrition has been identified as one of the most neglected, but important aspects of gastroenterology. "Clinical Nutrition in Gastrointestinal Disease" covers all of the vital aspects of nutrition and serves as the definitive resource on this topic.
Dr. Alan Buchman has teamed up with more than 70 world renowned leaders in the field to provide today's professional specializing in gastrointestinal disease with a practical guide that examines and explains the necessary elements and principles of nutrition. With more than 100 images and 180 tables, "Clinical Nutrition in Gastrointestinal Disease" contains essential information to optimally and successfully manage pediatric and adult patients.
Some Topics Covered Include:
- Nutritional assessment
- Nutrition in critical care
- Nutritional support
- Management of intestinal failure
- Obesity
- Pediatrics
- Probiotics
- Nutrient absorption
- Metabolism
- Home care

Some Gastrointestinal Diseases Covered Include:
- Inflammatory bowel disease
- Irritable bowel syndrome
- Colon cancer
- Pancreatititis
- Heptatic failure
- Celiac sprue
"Clinical Nutrition in Gastrointestinal Disease" delivers the latest information in a comprehensive and well-organized format that is perfect for gastroenterologists, general surgeons, and general internists looking to increase their knowledge of clinical nutrition. The extensive use of images, graphs, and tables compliments the text and makes this one of the most authoritative and thorough books on gastrointestinal disease currently on the market.

Get the essential tools you need to make an accurate diagnosis with Gastrointestinal Imaging, 4th Edition! Edited by Giles W. Boland, MD, this popular volume in The Requisites Series delivers the conceptual, factual, and interpretive information you need for effective clinical practice in gastrointestinal imaging. Master core knowledge the easy and affordable way with clear, concise text; new, high-quality images, and coverage of the latest modalities. Efficiently and affordably prepare for the written board exam and for clinical practice with focused, high-yield, richly illustrated coverage of the most essential concepts in gastrointestinal imaging. Make optimal use of the latest gastrointestinal imaging techniques with a significant new emphasis on CT and MR, including multi-slice CT, MR enterography, Diffusion-weighted MRI, hepatobiliary contrast agents for liver lesion detection and characterization, plus many other essential updates. See how gastrointestinal conditions present with a wealth of new multi-modal, high-quality digital images that mirror the findings you're likely to encounter in practice and on exams. Access the complete, fully searchable text and downloadable images online at www.expertconsult.com.

The area of gastrointestinal disorders is currently the focus of a large amount of sophisticated research. This volume brings fully up to date the most recent scientific and clinical advances in gastrointestinal and liver immunology. An international team of authorities has summarized basic scientific advances in the area of the gut immune system and the immune abnormalities relevant to gastrointestinal and liver disease. It includes the latest developments in relation to organ transplantation of the liver and gut, HIV infection of the gut, and the recently discovered disease H. pylori gastritis. Disorders of autoimmunity are focused on as well as immunodeficency. A feature of the volume is to highlight the relevance of such scientific advances to the clinical management of patients with immune gut and liver disorders. The volume will be an essential source of reference for all scientists interested in mucosal immunology, for clinical immunologists, gastroenterologists and hepatologists, transplant surgeons, and pediatricians.

Over two decades an abundance of knowledge has been accumulated focus ing on the understanding of the molecular and cellular pathomechanisms of stressful conditions like systemic inflammation and sepsis. We have learned that there is a clear correlation between the magnitude of the inciting traumatic event and the degree of inflammatory dysbalance. The immunoinflammatory disintegration comprises a simultaneous col lapse of the otherwise very smoothly balanced pro- and antiinflammatory vectors of cytokine regulation. Most recently, we understood that it is predominantly the dysregulation of antiinflammatory mediators that plays a pivotal role for the phenomenon of trauma-induced depression or paralysis of cell-mediated immune responses. The substantial intellectual and logistic investments of numerous investi gators towards understanding the biology of sepsis inevitably lead us towards a rewarding status in terms of reaching spheres of clinical relevance. From the evolutionary collection of a multitude of ex-vivo and in-vivo immuno mechanistic parameters, some were found to represent most significant bio logical markers to support the clinician to characterize better the severity of inflammatory illness and to predict outcome. Chapter one of this book, authored by G. Grass and E.A.M. Neugebauer, analyses elegantly our current knowledge on the assessment of the immuno logical status in terms of risk and prognosis of sepsis.

Relief at Last for the Millions of Chronic Heartburn Sufferers
Written by an internationally recognized expert on digestive diseases, this much-needed book brings relief to the tens of millions who suffer from the pain of severe heartburn almost daily. If you find yourself dependent on antacids, losing sleep, missing work, or canceling plans because of heartburn discomfort, you may be among those who struggle with gastroesophageal reflux disorder, or GERD. The good news is that your condition is treatable----especially in its early stages. Drawing from his extensive experience diagnosing and treating patients, as well as the latest research from around the globe, Dr. Anil Minocha explains the causes of heartburn----and the potentially serious consequences of leaving it untreated. In addition to providing an overview of the problem, Dr. Minocha offers invaluable information on:
* The latest treatment options-from nutrition and simple lifestyle changes to drugs, surgery, and alternative remedies
* How your diet and weight may be affecting your GERD
* The relationship between stress and heartburn
* Dealing with GERD during pregnancy, and in infants, children, and the elderly

""An in-depth analysis of how to heal heartburn and acid reflux, a problem that afflicts humans across the lifespan, from infancy to old age. . . . A valuable home reference.""-Elizabeth D. Tate, F.N.P., M.N., coauthor of Unforgettable Faces: Through the Eyes of a Nurse Practitioner
""Priceless and practical. . . . Easy to read. . . . A must-buy book for all heartburn sufferers.""-Joel E. Richter, M.D., F.A.C.P., F.A.C.G., Chairman, Department of Gastroenterology, The Cleveland Clinic Foundation

Relief at Last for the Millions of Chronic Heartburn Sufferers

Written by an internationally recognized expert on digestive diseases, this much-needed book brings relief to the tens of millions who suffer from the pain of severe heartburn almost daily. If you find yourself dependent on antacids, losing sleep, missing work, or canceling plans because of heartburn discomfort, you may be among those who struggle with gastroesophageal reflux disorder, or GERD. The good news is that your condition is treatable——especially in its early stages. Drawing from his extensive experience diagnosing and treating patients, as well as the latest research from around the globe, Dr. Anil Minocha explains the causes of heartburn——and the potentially serious consequences of leaving it untreated. In addition to providing an overview of the problem, Dr. Minocha offers invaluable information on:

• The latest treatment options–from nutrition and simple lifestyle changes to drugs, surgery, and alternative remedies
• How your diet and weight may be affecting your GERD
• The relationship between stress and heartburn
• Dealing with GERD during pregnancy, and in infants, children, and the elderly

"An in-depth analysis of how to heal heartburn and acid reflux, a problem that afflicts humans across the lifespan, from infancy to old age. . . . A valuable home reference."–Elizabeth D. Tate, F.N.P., M.N., coauthor of Unforgettable Faces: Through the Eyes of a Nurse Practitioner

"Priceless and practical. . . . Easy to read. . . . A must-buy book for all heartburn sufferers."–Joel E. Richter, M.D., F.A.C.P., F.A.C.G., Chairman, Department of Gastroenterology, The Cleveland Clinic Foundation

Gastroesophageal reflux (GER) refers to symptoms and events that result from abnormal regurgitation of gastric contents into the esophagus. GER is a common clinical problem that affects large segments of the general population. The spectrum of problems associated with GER is now known to also involve extra-esophageal sites. Respiratory diseases, in particular bronchial asthma, can be exacerbated by multiple triggers, including GER. The relationship between the occurrence of gastroesophageal disorders and changes in respiratory function has been known for over a century, but the mechanism by which intraesophageal acid regurgitation can produce respiratory symptoms is still debated. The reasons for these concurrent pathological events are also not fully understood. Determining, for instance, whether reflux itself initiates or exacerbates asthma, or whether asthma or its treatment primarily causes GER is a matter of current investigation.

Digestive Disease Week-Japan (DDW-Japan) was held successfully in Yokohama April 15-18, 1998, under the management of Prof. Yoshiki Hiki, Chairman of the Steering Committee. DDW-Japan was carried out with the cooperation and participa tion of gastroenterological societies in Japan. Because the participat ing congresses each dealt with topics characteristic of particular fields, all participants could enjoy a rewarding experience and could gather relevant, up-to-date information about a wide variety of subjects in basic and clinical medicine. Prof. Rikiya Fujita, Chairman of the International Relations Com mittee, planned and conducted the International Symposium working together with researchers from foreign countries, thus making DDW Japan in 1998 a great success. The symposium provided a fascinating insight into the global situation, and the papers that were present ed are being published in this monograph, Recent Advances in Gastroenterology. As we all know, the world soon is going to enter the third millen nium. Therefore, treatments and medicines should not be limited to any single country or small area; instead, medical knowledge must be shared as a global resource, without regard to nationality, way of life, or social system. I hope that this monograph will playa useful role in the develop ment of gastroenterology all over the world, and I very much appre ciate the tremendous contribution of all authors for this publication.

In the past several years much progress has been made in understanding the basic mechanisms of pancreatic physiology and the pathogenesis, diagnosis, and treatment of pancreatic disease. A symposium took place in Munich on 18-19 September 1998 that aimed at summarizing current knowledge of the exocrine pancreas and giving di rection to future research. It targeted all practitioners and scientists working in the field of exocrine pancreatic disease. The symposium was also designed to stimulate young persons embarking on a career in this area. It was an exciting meeting for all of us. We wish to extend our thanks to all participants for their prompt submission of manuscripts and to Springer Verlag for speedy publication, providing us with an up-to-date volume on pancreatic research. We would also like to thank G. Beyendorff-Hajda and W. Glockner, as well as D. Kriiger, representatives of Knoll Deutschland GmbH, for their organiza tional assistance and Knoll itself for its generous sponsorship, which enabled colleagues from other countries to participate and made publication of the symposium possible."

During the years that have intervened since the third volume of the International Life Seiences Institute (ILSI) Monographs on Pathology of Laboratory Animals, Digestive System, was published, new information of interest to pathologists has developed at a rather remarkable pace. Standardized nomenclature has been proposed and gained significant acceptance during the period since the first edition and isbeing utilized on aninternational basis. Thishas resulted in improvement in communi cationof pathologic data to reguiatory agencies and inscientific publica tions worldwide. This monograph series and others sponsored by ILSI have had significant effects on improved communications and the inter national acceptance of standardized nomenclature. In this second edition, new formats have been used in some instances where more appropriate for the subjects to be eovered. The format introduced in the first edition remains useful as it emphasizes the neces sityto reeognize the morphologie features of pathologic lesions to iden tify them precisely. This identifieation is an essential first step toward development of new insightsintopathogenetic meehanismsand their use in decisions eventually applieable to public health. Newinformation is included in thisedition on the nature and variability of preneoplastic lesions in the Iiver of laboratory rodents. Data on the aeeompanying changes in enzyme activity in affeeted Iiver cells are ex panded, and additional information on spongiosis hepatis in the rat and its relation to spongiotic pericytoma is a further feature. In a few in stanees, research on a pathologie entity has been Iimitedbut its recogni tionremains important. Thisjustifiesinclusion of suchentities in the new edition."

This is a histological classification of tumours and tumour-like lesions of the exocrine pancreas which also includes those tu- mours showing a mixture of exocrine and endocrine elements. The classification is based principally on standard microscopic observations, but whenever indicated it incorporates diagnosti- cally valuable immunohistological findings. In addition, the most important immunohistological findings which are helpful in cat- egorizing pancreatic tumours are summarised in Table 1. The major guideline of this classification scheme is the group- ing of the pancreatic exocrine tumours according to their biologi- cal behaviour. Thus, the neoplasms are broadly divided into benign (adenoma) and malignant tumours (carcinoma). How- ever, in recent years we have learned that this division is not a sharp but rather a gradual transition. We therefore added a third group which we call "tumours of uncertain malignant potential" representing a borderline category analogous to that recognized for some ovarian tumours. This group includes mucinous cystic tumour, intraductal papillary-mucinous tumour and solid- pseudopapillary tumour. These neoplasms are defined by the grade of dysplasia and/or potential to become malignant. Mucinous cystic tumours of uncertain malignant potential, for instance, exhibit moderate epithelial dysplasia, but do not show severe dysplasia/carcinoma in situ changes, nor carcinomatous invasion of the cyst wall or the adjacent pancreatic tissue. Solid- pseudopapillary tumour has a benign looking histological ap- pearance, but metastases may occur. Biologically, all these neoplasms are primarily slow-growing lesions and have an excel- lent prognosis when adequately treated by complete resection.

Jean-Claude Rambaud The place occupied today in basic and clinical research by intestinal disease related to Clostridium difficile is such that it is hard to remember that this range of disorders was completely identified only in 1977-1978, even though pieces of the puzzle had been identified much earlier. A brief historical review of the discovery of the enteropathogenicity of C. difficile in man might thus be useful. The bacterium was described in 1935 in the stools of infants, using the name Bacillus difficilis [7]. Until 1977, the microorganism, renamed C. difficile, considered to be of endogenous origin, was isolated only in rare cases of abscess or infection, most often unrelated to the digestive tract. Its role in genito-urinary infections [6] was not confirmed. However, the frequency of infant healthy carriers was recognized from the outset [7, 13]. Pseudo-membranous colitis (PMC) was described in 1883 following a gastroenterostomy. Many cases of this condition were published subsequently before the antibiotic era, describing various risk factors [4]. However the disease began to flourish only with the increasingly wide use of antibiotics. Antibiotic associated PMC was first described as an enterocolitis, though with little pathological evidence. It was principally related to the use of chloramphenicol and tetracyclines and attributed to proliferation of Staphylococcus au reus [ 11], a concept strengthened by the spectacular therapeutic action of vancomycin.

Recently, rapid developments have occurred in the field of viral gastroenteritis. This book is an update of fundamental and practical aspects of viral gastroenteritis. Among the various agents that cause viral gastroenteritis, group A rotaviruses and caliciviruses are the focus of this volume because of their clinical impact and the significance of new findings about them.

Biliary tract complications are still the major cause of morbidity following orthotopic liver transplantation. This book deals systematically with the large variety of possible cholangiographic changes. The figures are the results of a review of cholangiograms from more than 280 patients who underwent orthotopic liver transplantation. The etiology, clinical aspects, and treatment of these complications are reviewed on the basis of the authors' experience in radiology, endoscopy, and transplant surgery.

Constipation is a common disorder that is often defined differently by patients and physicians. Clinically, constipation occurs when bowel move ments are difficult or painful. The "normality" of bowel movements, in terms of frequency, varies among individuals; frequency that is thought by one person to be constipation may be reported by another to be usual and thus normal. Often the perceived "need" to have a bowel movement leads to self-treatment with laxatives as these drugs are widely available without a prescription. This situation can raise problems in patient care, because of potential interactions between laxatives and other medications. Furthermore, chronic use (abuse) oflaxatives can cause serious medical consequences, causing patients to visit physicians, and even to be hospitalized for further evaluation and care. This has a financial impact on the patient, and on health care systems. It is essential that pharmacists, physicians and other health care practitioners counsel patients on the causes of constipation and the proper use oflaxatives. A medical work-up by a physician should be done to determine if the constipation is due to a pathological process. Often nor mal bowel function (for an invididual) can be maintained by diet and/or lifestyle. Most laxatives in use today are of botanical origin. Further research on the mechanism of action of these and synthetic laxatives is needed to bet ter define their pharmacology and toxicology."